Table 6.
Plasma inflammatory cytokines concentration.
| pg/ml | N | WSC | CC | p |
|---|---|---|---|---|
| CCL-2 | 277 [239; 353] (n = 22) |
267 [209; 401] (n = 16) |
318 [265; 449] (n = 21) |
0.238 |
| IL-6 | 0.00 [0; 0.62] (n = 22) |
1.18 [0.01; 2.53] (n = 16) |
2.49 [0.85; 9.09]* (n = 21) |
<0.001 |
| IFN-γ | 1.28 [0.51; 1.91] (n = 20) |
1.70 [0.73; 3.05] (n = 16) |
1.48 [0.43; 3.37] (n = 20) |
0.418 |
| TNF-α | 5.04 [3.81; 6.15] (n = 22) |
6.80 [4.82; 9.68] (n = 16) |
7.52 [5.71; 10.2]* (n = 21) |
0.018 |
| IL-10 | 0.02 [0.01; 0.07] (n = 22) |
0.05 [0.01; 0.49] (n = 16) |
0.07 [0.04; 0.21] (n = 21) |
0.091 |
| IL-8 | 0.6 [0.4; 3.4] (n = 22) |
5.8 [3.5; 7.2]* (n = 16) |
21.1 [5.1; 44.6]* (n = 21) |
<0.001 |
| IL-1ra | 0.22 [0.15; 0.28] (n = 22) |
0.25 [0.18; 0.51] (n = 16) |
0.31 [0.22; 0.41] (n = 21) |
0.120 |
Data are expressed as median [1st quartile; 3rd quartile], p, significance level Kruskal-Wallis test.
CCL2, monocyte chemoattractant protein; IL-6, interleukin-6; IFN-γ, interferon gamma; TNF-α, Tumor necrosis factor-alpha; IL-10, interleukin-10; IL-8, interleukin-8; IL-1ra, receptor antagonist of interleukin-1.
*
Significant difference vs. N (p < 0.05).
p < 0.05 are highlighted in bold.